Onsdag 4 Juni | 19:57:28 Europe / Stockholm

Kalender

Est. tid*
2025-08-28 08:00 Kvartalsrapport 2025-Q2
2025-04-07 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2025-04-04 - Årsstämma
2025-03-07 - Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-04-05 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2024-04-04 - Årsstämma
2024-03-07 - Bokslutskommuniké 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-03-31 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2023-03-30 - Årsstämma
2023-03-02 - Bokslutskommuniké 2022
2022-08-25 - Kvartalsrapport 2022-Q2
2022-04-06 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2022-04-05 - Årsstämma
2022-03-02 - Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaFirst North Finland
SektorInformationsteknik
IndustriProgramvara
Aiforia Technologies utrustar patologer och forskare i prekliniska och kliniska laboratorier med programvara för att översätta bilder till upptäckter, beslut och diagnoser. Bolagets produkter och tjänster används för medicinsk bildanalys, över en mängd olika områden från onkologi till neurovetenskap. Aiforia Technologies har sitt huvudkontor i Finland.
2025-05-30 17:00:00

Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Sto-Rahoitus Oy’s holding in Aiforia Technologies Plc

Aiforia Technologies Plc, Company release, May 30, 2025 6:00p.m. EEST

Sto-Rahoitus Oy has informed Aiforia Technologies Plc that it has crossed below the 5% disclosure threshold on holding in shares and voting rights in Aiforia. According to the announcement, the holding passed underneath the threshold on May 28, 2025.

According to the notification, the reason for the notification was the event changing the breakdown of shares or voting rights.

Total positions of Sto-Rahoitus Oy subject to the notification:

 % shares and voting rights% of shares and voting rights through financial instrumentsTotal of both in %Total number of shares and voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached4.81% 4.81%31,464,954
Positions of previous notification (if applicable)5.83 % 5.83 %28,844,467

A: Shares and voting rights

 Number of shares and voting rights% of shares and voting rights  
Class/type of shares, ISIN codeDirect 
(AML 9:5)
Indirect 
(AML 9:6 and 9:7)
Direct 
(AML 9:5)
Indirect
(AML 9:6 and 9:7)
FI40005079341,514,810 4.81% 
SUBTOTAL1,514,8104.81%

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name% of shares and voting rights% of shares and voting rights through financial instrumentsTotal of both
Henrik Stormbom 33%   
Harriet Stormbom 33%   
Niklas Stormbom 33%   

Further inquiries
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc
tel. +358 405 009 878
https://investors.aiforia.com/

 

Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi

 

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com